These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 32998039)
1. The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials. Sixt T; Moretto F; Devilliers H; Abdallahoui M; Eberl I; Rogier T; Duong M; Salmon-Rousseau A; Mahy S; Buisson M; Esteve C; Chavanet P; Catherine FX; Blot M; Piroth L J Infect; 2021 Feb; 82(2):282-327. PubMed ID: 32998039 [No Abstract] [Full Text] [Related]
2. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study. Myrstad M; Ihle-Hansen H; Tveita AA; Andersen EL; Nygård S; Tveit A; Berge T Scand J Trauma Resusc Emerg Med; 2020 Jul; 28(1):66. PubMed ID: 32660623 [TBL] [Abstract][Full Text] [Related]
3. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. Bradley P; Frost F; Tharmaratnam K; Wootton DG; BMJ Open Respir Res; 2020 Dec; 7(1):. PubMed ID: 33293361 [TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19. Sze S; Pan D; Williams CML; Wong N; Sahota A; Bell D; Tang JW; Wiselka M; Stephenson I; Pareek M J Infect; 2021 Jan; 82(1):159-198. PubMed ID: 32479770 [No Abstract] [Full Text] [Related]
5. The COVID-19 Army Rapid Assessment Tool (CARAT) for Management of COVID-19 in the Deployed Setting. Walters MJ; Aden BL; Kliewer ML; Bruehl CL; Mannion EM; Smith AL; Clark AD; Sachdeva M; Teplicki HR; Honea CW; Ward DE; Venable CA; Wolloff SA Med J (Ft Sam Houst Tex); 2021; (PB 8-21-01/02/03):150-155. PubMed ID: 33666929 [TBL] [Abstract][Full Text] [Related]
6. Prospective validation and comparison of COVID-GRAM, NEWS2, 4C mortality score, CURB-65 for the prediction of critical illness in COVID-19 patients. Yildiz H; Castanares-Zapatero D; Hannesse C; Vandermeersch D; Pothen L; Yombi JC Infect Dis (Lond); 2021 Aug; 53(8):640-642. PubMed ID: 33691577 [No Abstract] [Full Text] [Related]
7. The CALL Score for Predicting Outcomes in Patients With COVID-19. Grifoni E; Valoriani A; Cei F; Vannucchi V; Moroni F; Pelagatti L; Tarquini R; Landini G; Masotti L Clin Infect Dis; 2021 Jan; 72(1):182-183. PubMed ID: 32474605 [No Abstract] [Full Text] [Related]
8. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360 [TBL] [Abstract][Full Text] [Related]
9. NEWS2 is a valuable tool for appropriate clinical management of COVID-19 patients. Rigoni M; Torri E; Nollo G; Delle Donne L; Cozzio S Eur J Intern Med; 2021 Mar; 85():118-120. PubMed ID: 33358535 [No Abstract] [Full Text] [Related]
11. COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital. Ihle-Hansen H; Berge T; Tveita A; Rønning EJ; Ernø PE; Andersen EL; Wang CH; Tveit A; Myrstad M Tidsskr Nor Laegeforen; 2020 May; 140(7):. PubMed ID: 32378844 [TBL] [Abstract][Full Text] [Related]
12. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection. Yang Y; Hu X; Xiong L; Fu P; Feng W; Li W; Zhang L; Sun F BMC Infect Dis; 2021 Feb; 21(1):141. PubMed ID: 33535989 [TBL] [Abstract][Full Text] [Related]
14. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Aggarwal S; Garcia-Telles N; Aggarwal G; Lavie C; Lippi G; Henry BM Diagnosis (Berl); 2020 May; 7(2):91-96. PubMed ID: 32352401 [TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
16. Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19). Salbach C; Mueller-Hennessen M; Biener M; Stoyanov KM; Vafaie M; Preusch MR; Kihm LP; Merle U; Schnitzler P; Katus HA; Giannitsis E PLoS One; 2021; 16(2):e0247488. PubMed ID: 33606842 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115 [TBL] [Abstract][Full Text] [Related]
18. Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure. Kodama T; Kouzaki Y; Kawano S; Obinata H; Taniguchi H; Sasaki H; Ota S; Kawana A; Tamura K J Infect Chemother; 2020 Nov; 26(11):1220-1223. PubMed ID: 32792249 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study. Kathuria-Prakash N; Mosaferi T; Xie M; Antrim L; Angell TE; In GK; Su MA; Lechner MG Endocr Pract; 2021 Feb; 27(2):90-94. PubMed ID: 33551317 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran. Abolnezhadian F; Makvandi M; Alavi SM; Azaran A; Jalilian S; Rashno M; Kaydani GA; Arshadi M; Hosseinizadeh SM; Boostani H; Seyedian SS; Moogahi S; Salmanzadeh S; Varnaseri M; Neisi N; Keifarrokhi H; Shariati G; Amiri H; Parsanahad M; Nashibi R; Yousefi F; Ahmadi F; AhmadiAngali K Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):471-477. PubMed ID: 33463114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]